InvestorsHub Logo
Followers 38
Posts 1440
Boards Moderated 0
Alias Born 03/07/2004

Re: jimsgtx post# 160702

Tuesday, 02/11/2014 11:55:44 PM

Tuesday, February 11, 2014 11:55:44 PM

Post# of 346054
jim, you have probably seen this summary of current concepts in MAB treatment of CLL, Curr Cancer Drug Targets. 2008 Mar;8(2):156-71.Novel monoclonal antibodies for the treatment of chronic lymphocytic leukemia. Robak T.
Obviously I would fight like crazy to obtain Bavituximab treatment for myself in such circumstances, and it would be a battle because oncologists are held to "the standard of care", and can be sued for suggesting something which is clearly outside that standard. Also, it is a huge hassle for an oncologist to jump through the hoops. Even though congress and the FDA are on record as supporting easier access, the reality is often the opposite. It can be done. Start early on the "compassionate use" pathway. You can help a lot of people here while helping yourself if you keep us posted on your progress along that path. Good luck!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News